Mucowon Capsule (Erdosteine)

Adult dose

Adults: Administer 300 mg of erdosteine orally 2～3 times daily. When administered for acute respiratory diseases, do not use continuously for more than 10 days.

It is important that this medicine is not used for certain patients. First, it should not be administered to patients with a history of allergic reactions to this medicine or any of its components. Patients with liver cirrhosis or those whose metabolic products of this medication may cause problems in their body due to specific enzyme deficiencies should also avoid using it. This medication is not suitable for patients with peptic ulcers, severely impaired kidney function, and significantly reduced liver function. Caution is necessary when this medication is used in patients with mild to moderate liver impairment. In this case, the daily dosage should not exceed 300 mg. Additionally, this medication contains a dye called Yellow No. 5, so it should be used cautiously in patients who are allergic or have had hypersensitivity reactions to that ingredient. Symptoms such as sweating, dizziness, and flushing may occur in case of overdose. Neurological and respiratory symptoms such as headache, cold symptoms, and difficulty breathing have also been reported. Gastrointestinal symptoms may include altered taste, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Skin symptoms such as urticaria, erythema, and eczema could appear, so it is essential to be cautious if any unusual symptoms occur. Caution is required when using this medication with other drugs. In particular, taking it with cough medications may make mucus expulsion difficult, increasing the risk of bronchial infections and causing bronchoconstriction, so care should be taken. Use during pregnancy or in women of childbearing potential, and in nursing mothers is not recommended for this medication. Although no specific harm has been found in animal studies, the safety in humans has not been sufficiently proven. Finally, this medication should be kept out of reach of children and should not be transferred to other containers as it may cause quality degradation or accidents.

• sweating
• dizziness
• flushing
• headache
• cold
• dyspnea
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

This medication may interact when taken with cough medications; therefore, consultation with a doctor or pharmacist is recommended.

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve the medication's efficacy.

Appearance

Hard capsule with a green upper part and a yellowish lower part containing white powder

Package unit

30 capsules/bottle, 100 capsules/bottle